This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Mary Stewart: Innovator in Genetic Research
Introduction
Mary Stewart is a prominent inventor based in Fargo, ND (US). She has made significant contributions to the field of genetic research, particularly through her innovative work on Drosophila melanogaster p70 S6 kinase. With a total of 2 patents, her inventions have advanced the understanding of kinase activity and its implications in various biological processes.
Latest Patents
Mary Stewart's latest patents focus on the Drosophila melanogaster p70 S6 kinase. The first patent provides p70, along with nucleic acids encoding this kinase. The sequences of p70 and the gene encoding it are represented in SEQ ID No. 2 and 1, respectively. This invention also includes mutated forms of p70, such as constitutively active and dominant negative forms, which are useful for studying p70 activity. Additionally, the invention offers expression systems that produce p70 in Drosophila and other organisms, facilitating the study of its activity through modulated expression.
Career Highlights
Mary Stewart is currently associated with Novartis AG, where she continues to contribute to groundbreaking research in genetics. Her work has garnered attention for its potential applications in understanding cellular processes and developing therapeutic strategies.
Collaborations
Mary has collaborated with notable coworkers, including Sara Kozma and George Thomas, who have supported her research endeavors.
Conclusion
Mary Stewart's innovative work in genetic research, particularly her patents related to Drosophila melanogaster p70 S6 kinase, showcases her significant contributions to the field. Her ongoing research at Novartis AG continues to pave the way for advancements in understanding kinase activity and its biological implications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
